Concepedia

Eliel Bayever

EB

Statistics

Publications

34

Citations

2.6K

H-Index

21

Active since

1984

Affiliations

University of Nebraska Medical Center(Current)

University of Pennsylvania

Children's Hospital of Philadelphia

Merrimack Pharmaceuticals (United States)

Roswell Park Comprehensive Cancer Center

Eliel Bayever is an author at University of Nebraska Medical Center specializing in medicine, oncology, and chemotherapy.

Publications per year

1984–2020

34

Publications

34

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial

Andrea Wang‐Gillam, Chung‐Pin Li, G. Bodoky et al. · The Lancet · 2015 · 1.2K citations

, , +16

Correlation between Ferumoxytol Uptake in Tumor Lesions by MRI and Response to Nanoliposomal Irinotecan in Patients with Advanced Solid Tumors: A Pilot Study

Ramesh K. Ramanathan, Ronald L. Korn, Natarajan Raghunand et al. · Clinical Cancer Research · 2017 · 172 citations

, , +17

Systemic Administration of a Phosphorothioate Oligonucleotide with a Sequence Complementary to p53 for Acute Myelogenous Leukemia and Myelodysplastic Syndrome: Initial Results of a Phase I Trial

Eliel Bayever, Patrick L. Iversen, Michael Bishop et al. · Antisense Research and Development · 1993 · 150 citations

, , +17

Phase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignancies.

Michael Bishop, Patrick L. Iversen, Eliel Bayever et al. · Journal of Clinical Oncology · 1996 · 141 citations

, , +14

BONE-MARROW TRANSPLANTATION FOR METACHROMATIC LEUCODYSTROPHY

Eliel Bayever, Michel Philippart, Marc R. Nuwer et al. · The Lancet · 1985 · 81 citations

, , +5

1–5 of 34